This session will provide cancer nurses with up-to-date insights into the management of high-risk locally advanced cervical cancer (LACC), with a focus on integrating immunotherapy and radiotherapy into practice.
The learning objectives for this session include:
- Review the latest evidence-based treatment regimens for high-risk LACC, including immuno-radiotherapy combinations.
- Enhance clinical skills in recognizing and managing immune-related adverse events associated with pembrolizumab.
- Discuss radiation therapy-specific toxicities, with practical strategies for mitigation.
- Share experiences and strategies for managing treatment-related adverse events.
Practical, evidence-informed, and designed for nurses working at the frontline of cancer care—this webinar equips you with the knowledge and confidence to deliver safer, more effective treatment for women with LACC.
Speakers
Yolande Cox
